NgoJulayi 2021: I-US Food and Medication Administration (FDA) inwebise izinkomba ze-pembrolizumab (Keytruda), umuthi we-immunotherapy, ukuze ihlanganise noma yimuphi umdlavuza onomthwalo omkhulu wokuguqula (TMB-H). Isigunyazo esisha sithi f..